Previous close | 295.80 |
Open | 295.80 |
Bid | 283.70 x 0 |
Ask | 284.40 x 0 |
Day's range | 295.80 - 295.80 |
52-week range | 209.50 - 305.80 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 26 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Robust Revenue Growth and Strategic Acquisitions Highlight the Quarter
While the top- and bottom-line numbers for HCA (HCA) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
HCA (HCA) delivered earnings and revenue surprises of 6.99% and 2.93%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?